Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
ALNEV.PAthis companyNeovacs S.A.	€0.09	-669.23×	180.66×	20,138.85×	-621.56×	-102.4%	-2796.5%	-3354.8%	-3026.8%	-27.2%	-24.6%	-0.2%	0.03×	0.01×	-5.79×	0.84×	0.0%	3	-4.72	1	C-
ALBPS.PABiophytis S.A.	€0.04	-0.19×	-0.2×	0×	-1.43×	-7126.2%	0.0%	0.0%	0.0%	107.4%	-2242.7%	-438.4%	-1.02×	-1.19×	-9.75×	0.25×	0.0%	1	-10.97	—	—
ALCLS.PACellectis S.A.	€1.05	-7.05×	6.52×	6.52×	-24.8×	-443.6%	72.5%	-55.3%	-92.7%	-92.7%	-19.9%	-8.9%	1.2×	-1.38×	-4.98×	1.62×	0.0%	2	-1.71	1	D+
ALEUP.PAEuroplasma S.A.	€0.00	-0.03×	-0.06×	0.02×	-0.66×	-48279948.6%	42.9%	-41.4%	-50.5%	167.6%	-251.1%	-1651.0%	-0.94×	-0.6×	-3.5×	0.66×	0.0%	4	-5.79	2	C
ALALTME.PATME Pharma N.V.	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
IPH.PAInnate Pharma S.A.	€1.31	-2.91×	-6.59×	51.33×	-2.46×	-112.1%	100.0%	-2058.0%	-1764.5%	226.6%	-146.1%	-37.0%	-1.04×	0.1×	-18.38×	1.27×	0.0%	3	-22.95	2	C
Peer median	—	-1.55×	-0.13×	3.27×	-1.94×	-3784.9%	57.7%	-48.4%	-71.6%	137.5%	-198.6%	-237.7%	-0.98×	-0.9×	-7.36×	0.97×	0.0%	3	-8.38	2	—